Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia 54Myelodysplastic Syndromes 42Lymphoma, Non-Hodgkin 19Congenital Abnormalities 15Lymphoma 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leukemia, Lymphocytic, Chronic, B-Cell 13Hodgkin Disease 13Recurrence 11Leukemia, Myelomonocytic, Chronic 11Leukemia, Myelomonocytic, Acute 10Leukemia, Monocytic, Acute 10Leukemia, Megakaryoblastic, Acute 10Leukemia, Erythroblastic, Acute 10Leukemia, Biphenotypic, Acute 9Hematologic Neoplasms 9Neoplasms 8Multiple Myeloma 7Burkitt Lymphoma 7Anemia, Refractory, with Excess of Blasts 7Leukemia, Myelomonocytic, Juvenile 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Promyelocytic, Acute 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Graft vs Host Disease 5Lymphoma, Mantle-Cell 4

Interventions

fludarabine 2Metformin 2Busulfan 2thymoglobulin 1fludarabine phosphate 1bicalutamide 1Testosterone 1Saline Solution 1Powders 1Nutrition Assessment 1Mesna 1Melphalan 1Magnetic Resonance Imaging 1Influenza Vaccines 1Honey 1Heparin 1Gonadotropin-Releasing Hormone 1Gastric Bypass 1Exercise 1Eating 1Cyclophosphamide 1Clofarabine 1Caloric Restriction 1Antineoplastic Agents 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolic Diseases × Clofarabine × Clear all
NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡